Work

Zoledronic acid in patients with stage IIIA/B NSCLC: results of a randomized, phase III study

Year: 2012

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mds128

Authors: G.V. Scagliotti, P. Kosmidis, F. de Marinis, A.J.M. Schreurs, I. Albert, W. Engel-Riedel, D. Schallier, S. Barbera, H.-P. Kuo, V. Sallo, J.R. Perez, C. Manegold

Institutions: University of Turin, Hygeia Hospital, Jeroen Bosch Ziekenhuis, Lungenklinik Köln-Merheim, Universitair Ziekenhuis Brussel, Chang Gung Memorial Hospital, Heidelberg University, University Medical Centre Mannheim

Language: English

Topic: Bone health and treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Eli Lilly and Company, AstraZeneca, Novartis Pharmaceuticals Corporation

OpenAlex ID: W2139705209

FWCI: 2.533

Cites: 23

Cited by: 38

Related to: 10